Stay updated on Tivozanib Plus Nivolumab in RCC: Clinical Trial
Sign up to get notified when there's something new on the Tivozanib Plus Nivolumab in RCC: Clinical Trial page.

Latest updates to the Tivozanib Plus Nivolumab in RCC: Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedUpdated the site footer to display Revision: v3.4.2, replacing the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0. This is a minor site version update and does not affect the study details.SummaryDifference0.1%

- Check32 days agoChange DetectedShow glossary was added and there are minor text/metadata updates (capitalization of 'Met' and 'Data', and the revision tag v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check39 days agoChange DetectedThe page now displays Revision: v3.3.4 in the header, replacing the previous v3.3.3; this is a minor site UI update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange Detected- Revision: v3.3.3 added and HHS Vulnerability Disclosure link removed; these footer/site-wide changes do not alter the study details on the page.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page. No core study content or functionality appears to be affected.SummaryDifference0.1%

Stay in the know with updates to Tivozanib Plus Nivolumab in RCC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tivozanib Plus Nivolumab in RCC: Clinical Trial page.